Related Experiment Video
Updated: Feb 28, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Transforming Cancer Care with Oncosomes: Insight into Biogenesis, Functional Role, and Therapeutic Potential
Popat Mohite1, Rajesh Bogati1, Aishwarya Gorad1
1AET's St. John Institute of Pharmacy and Research, Palghar 401404, Maharashtra, India.
Oncosomes, large vesicles from tumor cells, show promise for targeted cancer drug delivery. Research is exploring their potential despite challenges in isolation and loading for clinical use.
Area of Science:
- Oncology
- Biotechnology
- Extracellular Vesicles
Background:
- Oncosomes are large extracellular vesicles released by tumor cells.
- They contain oncogenic proteins, nucleic acids, and lipids, facilitating tumor communication.
- Oncosomes are being investigated as potential drug delivery vehicles in cancer research.
Purpose of the Study:
- To review current knowledge on oncosome biogenesis, composition, and roles in cancer progression.
- To critically evaluate methods for oncosome isolation, characterization, and cargo loading.
- To discuss challenges and future perspectives for engineered oncosomes in cancer therapy.
Main Methods:
- Literature review of preclinical studies and existing methodologies.
- Analysis of oncosome biogenesis, molecular composition, and cargo transport.
- Evaluation of isolation and loading techniques (incubation, electroporation, sonication, etc.).
Main Results:
- Oncosomes possess large cargo capacity and biological compatibility for drug delivery.
- Current evidence is largely proof-of-concept from in vitro and animal models.
- Significant challenges include vesicle heterogeneity, low loading efficiency, and manufacturing constraints.
Conclusions:
- Engineered oncosomes offer a promising experimental platform for personalized cancer research.
- Addressing technical and translational barriers is crucial for clinical application.
- Further research is needed to overcome limitations in large-scale production and safety.
More Related Videos
05:33Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...